Growth Metrics

Ardelyx (ARDX) Cash from Investing Activities Growth (1y) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Growth (1y) (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - -114.28%
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn 826.39%
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn -674.01%
7 Evaxion A 64.16 Bn 64.14 Bn - -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn -166.24%
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn -122.45%
10 Ardelyx 1.48 Bn 1.25 Bn 89.66 Mn -450.58%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -450.58%
Dec 31, 2025 109.07%
Sep 30, 2025 -2,257.58%
Jun 30, 2025 48.40%
Mar 31, 2025 210.85%
Dec 31, 2024 -40.77%
Sep 30, 2024 107.16%
Jun 30, 2024 139.75%
Mar 31, 2024 73.69%
Dec 31, 2023 -2,151.84%
Sep 30, 2023 -3,829.93%
Jun 30, 2023 -482.62%
Mar 31, 2023 -519.25%
Dec 31, 2022 -93.48%
Sep 30, 2022 -104.59%
Jun 30, 2022 87.93%
Mar 31, 2022 -6.16%
Dec 31, 2021 718.94%
Sep 30, 2021 89.00%
Jun 30, 2021 -38.63%
Mar 31, 2021 104.88%
Dec 31, 2020 93.56%
Sep 30, 2020 -59.08%
Jun 30, 2020 -47.19%
Mar 31, 2020 -269.72%
Dec 31, 2019 -349.94%
Sep 30, 2019 132.34%
Jun 30, 2019 141.62%
Mar 31, 2019 2,741.50%
Dec 31, 2018 97.75%
Sep 30, 2018 -31.85%
Jun 30, 2018 -474.65%
Mar 31, 2018 -104.94%
Dec 31, 2017 118.95%
Sep 30, 2017 120.75%
Jun 30, 2017 5,623.05%
Mar 31, 2017 11,584.00%
Dec 31, 2016 -12,945.81%
Sep 30, 2016 -10,393.09%
Jun 30, 2016 76.68%
Mar 31, 2016 81.04%
Dec 31, 2015 56.01%
Sep 30, 2015 -672.73%
Jun 30, 2015 -97.04%
Mar 31, 2015 -1,022.34%
Sep 30, 2014 -319.05%